Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia

Max J. Gordon, Philipp W. Raess, Kathleen Young, Stephen E.F. Spurgeon, Alexey V. Danilov

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia'. Together they form a unique fingerprint.